Antibody Therapy for Enterovirus EV-D68 Infection
$299,959N01FY2020AINIH
Hdt Bio Corporation, Seattle WA
Investigators
Abstract
To develop antibody therapy for Enterovirus EV-D68 infection for use in children.
View original record on NIH RePORTER →Hdt Bio Corporation, Seattle WA
To develop antibody therapy for Enterovirus EV-D68 infection for use in children.
View original record on NIH RePORTER →